163 related articles for article (PubMed ID: 3937832)
1. Derivation of a brain tumor-selective monoclonal antibody from hybridoma between mouse myeloma and rat spleen cells immune to syngeneic glioma.
Saya H; Masuko T; Hashimoto Y
Jpn J Cancer Res; 1985 Dec; 76(12):1198-202. PubMed ID: 3937832
[TBL] [Abstract][Full Text] [Related]
2. Detection of human glioma-associated antigen by rat monoclonal antibody raised against syngeneic rat glioma cells.
Saya H; Masuko T; Kokunai T; Yagita H; Ijichi A; Taomoto K; Tamaki N; Matsumoto S; Hashimoto Y
J Neurosurg; 1986 Oct; 65(4):495-502. PubMed ID: 3760959
[TBL] [Abstract][Full Text] [Related]
3. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.
Ciesielski MJ; Kazim AL; Barth RF; Fenstermaker RA
Cancer Immunol Immunother; 2005 Feb; 54(2):107-19. PubMed ID: 15340764
[TBL] [Abstract][Full Text] [Related]
4. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
5. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
[TBL] [Abstract][Full Text] [Related]
6. Human glioma-associated antigens detected by monoclonal antibodies.
Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N
Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861
[TBL] [Abstract][Full Text] [Related]
7. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
8. Highly selective recognition of human neuroblastoma cells by mouse monoclonal antibody to a cytoplasmic antigen.
Gross N; Beck D; Carrel S; Munoz M
Cancer Res; 1986 Jun; 46(6):2988-94. PubMed ID: 3516388
[TBL] [Abstract][Full Text] [Related]
9. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells.
Masuko T; Abe J; Yagita H; Hashimoto Y
Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712
[TBL] [Abstract][Full Text] [Related]
10. Serologic analysis of nitrosourea-induced rat gliomas.
Pfreundschuh M; Cravioto H; Hochwald G; Ransohoff J
J Natl Cancer Inst; 1982 Mar; 68(3):501-5. PubMed ID: 6950179
[TBL] [Abstract][Full Text] [Related]
11. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
14. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.
Hellström I; Hellström KE; Rollins N; Lee VK; Hudkins KL; Nepom GT
Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770
[TBL] [Abstract][Full Text] [Related]
16. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors.
Stavrou D; Süss C; Bilzer T; Kummer U; De Tribolet N
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1439-49. PubMed ID: 6196200
[TBL] [Abstract][Full Text] [Related]
18. [Histologic distribution of anti-glioma monoclonal antibody SZ-39 in human xenograft brain tumors].
Yang WL
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):82-4. PubMed ID: 2806047
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
20. Immunological aspects of experimental brain tumors (review).
Stavrou D; Bilzer T; Hultén M; Zänker KS; Anzil AP; Haglid KG; Dahme E
Anticancer Res; 1982; 2(3):151-5. PubMed ID: 6751209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
